1. Identification of melanoma antigens that are immunogenic in humans and expressed in vivo;Applebaum;J Natl Cancer Inst,1998
2. Treatment of human melanoma with a hapten modified autologous vaccine;Berd;Ann NY Acad Sci,1993
3. Induction of IgG antibodies directed to a Mr 31,000 melanoma antigen in patients immunized with vaccinia virus melanoma oncolysates;Bertier-Vergnes;Cancer Res,1994
4. Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma associated antigens;Bystryn;J Immunol,1978
5. Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens;Bystryn;Ann NY Acad Sci,1993